Biggest News Aggregation in the World
📰 Alan Tyndall News

Alan Tyndall News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alan Tyndall. Real-time updates on events, politics, business and more.

Short Interest in Magenta Therapeutics, Inc. (NASDAQ:MGTA) Rises By 21.2%

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 495,600 shares, an increase of 21.2% from the May 15th total of 408,800 shares. Based on an average daily volume of 504,400 shares, the days-to-cover ratio is […]
United Kingdom Davidt Scadden Alan Tyndall Johnf Dipersio Luigi Naldini Robert Negrin

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Short Interest Down 56.0% in May

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on […]
United Kingdom Luigi Naldini Alan Tyndall Robert Negrin Davidt Scadden Johnf Dipersio
Source: wkrb13.com

Inspire Corporate Bond ETF Announces Dividend of $0.07 (NYSEARCA:IBD)

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Based on an average trading volume of 514,400 shares, the […]
United Kingdom Robert Negrin Davidt Scadden Derrickj Rossi Johnf Dipersio Luigi Naldini

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Expected to Post Q2 2023 Earnings of ($0.19) Per Share

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Stock analysts at Wedbush boosted their Q2 2023 earnings per share (EPS) estimates for Magenta Therapeutics in a research report issued on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.19) for the quarter, up from their […]
United Kingdom Luigi Naldini Johnf Dipersio Alan Tyndall Davidt Scadden Robert Negrin

Magenta Therapeutics, Inc. (NASDAQ:MGTA) Sees Significant Drop in Short Interest

Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,060,000 shares, a drop of 10.9% from the March 31st total of 1,190,000 shares. Currently, 2.4% of the company’s shares are short sold. Based […]
United Kingdom Davidt Scadden Alan Tyndall Robert Negrin Luigi Naldini Johnf Dipersio

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science